Novotech Recognised as 2024 Global CRO Leader by Frost & Sullivan

• Novotech awarded Frost & Sullivan’s 2024 Global Company of the Year Award.

• Recognition highlights Novotech’s innovation, global reach, and commitment to biotech clients.

Novotech, a global full-service clinical contract research organisation (CRO), has been awarded the 2024 Global Company of the Year Award by Frost & Sullivan. This award recognises the company’s ability to drive innovation in clinical development, offer advanced technological solutions, and maintain a comprehensive global presence.

The award acknowledges Novotech’s full-service approach to clinical trials, which leverages advanced analytics, access to diverse patient populations, and specialised technologies to accelerate drug development for its biotech clients. Novotech’s understanding of local regulations and cultural nuances has been a key factor in establishing itself as a leading global CRO.

Unmesh Lal, Global Research Director at Frost & Sullivan, commented, “Novotech distinguishes itself in the expanding CRO market by addressing the complex regulatory landscape and cultural barriers. This positions the company as a global partner with regional leadership and localised expertise.”

Novotech’s global reach and expertise enable it to deliver tailored solutions that optimise trial efficiency and patient recruitment. The company’s project manager-centric model ensures effective communication and collaboration with clients throughout the trial process. In addition, Novotech continues to invest in cutting-edge technologies, such as artificial intelligence, big data analytics, and cloud-based platforms, to enhance trial planning and transparency.

CEO of Novotech, Dr John Moller, said, “We are deeply honoured to receive the 2024 Global Company of the Year Award. This recognition reflects the dedication of our team and our commitment to delivering exceptional results for biotech and pharmaceutical clients.”

This is the first time Novotech has received the Global Company of the Year Award, having previously been recognised as the best CRO in the Asia-Pacific region every year since 2006.